Cytokinetics Elects New Directors, Updates Executive Pay
Ticker: CYTK · Form: 8-K · Filed: Aug 15, 2024 · CIK: 1061983
| Field | Detail |
|---|---|
| Company | Cytokinetics Inc (CYTK) |
| Form Type | 8-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.001, $560,000, $100,000, $1,891,620, $833,520 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: CYTK
TL;DR
Cytokinetics adds 2 directors, updates CEO/CFO pay packages.
AI Summary
Cytokinetics, Incorporated announced on August 13, 2024, changes in its board of directors and executive compensation arrangements. Specifically, the company elected two new directors, Dr. Andrew W. Lo and Ms. Michelle L. Griffin, to its Board of Directors. Additionally, the company entered into new employment agreements with its Chief Executive Officer, Robert Iannone, and Chief Financial Officer, Robert J. Alexander, effective August 13, 2024, detailing their compensation.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance and executive compensation updates, with no immediate financial distress or significant operational changes indicated.
Key Players & Entities
- Cytokinetics, Incorporated (company) — Registrant
- Dr. Andrew W. Lo (person) — Newly elected director
- Ms. Michelle L. Griffin (person) — Newly elected director
- Robert Iannone (person) — Chief Executive Officer
- Robert J. Alexander (person) — Chief Financial Officer
- August 13, 2024 (date) — Effective date of changes
FAQ
Who were the new directors elected to Cytokinetics' Board of Directors?
Dr. Andrew W. Lo and Ms. Michelle L. Griffin were elected as new directors.
When were the new employment agreements for the CEO and CFO effective?
The new employment agreements for Robert Iannone and Robert J. Alexander were effective August 13, 2024.
What is Cytokinetics' principal executive office address?
The principal executive offices are located at 350 Oyster Point Boulevard, South San Francisco, California 94080.
What is the Commission File Number for Cytokinetics?
Cytokinetics' Commission File Number is 000-50633.
What is the IRS Employer Identification Number for Cytokinetics?
Cytokinetics' IRS Employer Identification Number is 94-3291317.
Filing Stats: 1,501 words · 6 min read · ~5 pages · Grade level 14.2 · Accepted 2024-08-15 16:00:08
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value CYTK The Nasdaq Global Se
- $560,000 — 's annual base salary will initially be $560,000, and he will be entitled to participate
- $100,000 — er will also be paid a signing bonus of $100,000, which will be subject to repayment sho
- $1,891,620 — stock units with a grant date value of $1,891,620 (based on the closing price of the Comp
- $833,520 — stock units with a grant date value of $833,520 (based on the closing price of the Comp
Filing Documents
- cytk-20240813.htm (8-K) — 44KB
- 0000950170-24-097556.txt ( ) — 157KB
- cytk-20240813.xsd (EX-101.SCH) — 24KB
- cytk-20240813_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CYTOKINETICS, INCORPORATED Date: August 15, 2024 By: /s/ John O. Faurescu John O. Faurescu, Esq. Vice President, Associate General Counsel & Secretary